ALERTS: DISTRIBUTION – SECTOR INQUIRY – HEALTHCARE – PHARMACEUTICAL SECTOR

Sector inquiry: The French Competition Authority conducts an initial assessment of the sector inquiry about the functioning of competition in pharmaceutical and medical biology sectors and launches a public consultation (Healthcare)

*This article is an automatic translation of the original article in French, provided here for your convenience. Read the original article. After several opinions issued in recent years on the functioning of competition in the medicinal products sector, with mixed success as we know, the Authority, it will be remembered, decided to launch in November 2017A sector inquiry into the functioning of competition in the pharmaceutical and medical biology sectors. This ongoing inquiry focuses on two areas: the functioning of the drug distribution chain and the conditions for setting drug prices. Achieved a first progress report With regard to the functioning of

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

  • L’actu-concurrence (Paris)

Quotation

Alain Ronzano, Sector inquiry: The French Competition Authority conducts an initial assessment of the sector inquiry about the functioning of competition in pharmaceutical and medical biology sectors and launches a public consultation (Healthcare), 18 October 2018, Concurrences N° 1-2019, Art. N° 88445, www.concurrences.com

Visites 217

All reviews